Intrarosa FDA Approval History
FDA Approved: Yes (First approved November 17, 2016)
Brand name: Intrarosa
Generic name: prasterone
Dosage form: Vaginal Inserts
Company: Endoceutics Inc.
Treatment for: Dyspareunia
Intrarosa (prasterone) is a once-daily, vaginally administered steroid indicated to treat postmenopausal women experiencing moderate to severe pain during sexual intercourse (dyspareunia) as a symptom of vulvar and vaginal atrophy.
Development timeline for Intrarosa
| Date | Article |
|---|---|
| Nov 17, 2016 | Approval FDA Approves Intrarosa (prasterone) for Postmenopausal Women Experiencing Dyspareunia |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
